Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wilms tumour: a developmental anomaly.

N D Hastie1, W Bickmore, K Pritchard-Jones

  • 1MRC Human Genetics Unit, Western General Hospital, Edinburgh, U.K.

Princess Takamatsu Symposia
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland-Does Variation Matter?

Pediatric blood & cancer·2026
Same author

Fifty years of clinical and research studies for childhood renal tumors within the International Society of Pediatric Oncology (SIOP).

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001.

PloS one·2019
Same author

The European study on centralisation of childhood cancer treatment.

European journal of cancer (Oxford, England : 1990)·2019
Same author

The role of neuroticism in self-harm and suicidal ideation: results from two UK population-based cohorts.

Social psychiatry and psychiatric epidemiology·2019
Same author

Evidence-based data and rare cancers: The need for a new methodological approach in research and investigation.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2018
Same journal

Survival after liver transplantation in patients with hepatocellular carcinoma.

Princess Takamatsu symposia·1995
Same journal

Surgical treatment of hepatocellular carcinoma.

Princess Takamatsu symposia·1995
Same journal

Treatment of unresectable hepatocellular carcinoma: targeted therapies using iodized oil.

Princess Takamatsu symposia·1995
Same journal

The present status of treatments for hepatocellular carcinoma.

Princess Takamatsu symposia·1995
Same journal

Prospects for prophylactic and therapeutic hepatitis C virus vaccines.

Princess Takamatsu symposia·1995
Same journal

Association of cytotoxic T lymphocyte (CTL) escape mutations with persistent hepatitis C virus (HCV) infection.

Princess Takamatsu symposia·1995
See all related articles

Wilms tumour (WT) is a kidney developmental anomaly linked to chromosome 11 tumor suppressor genes. Research suggests WT gene defects may cause WAGR syndrome

Area of Science:

  • Nephrology
  • Genetics
  • Developmental Biology

Background:

  • Wilms tumour (WT) is a pediatric kidney cancer arising from developmental anomalies.
  • WT is associated with the loss of function of tumor suppressor genes on chromosome 11.
  • The WAGR syndrome (Wilms tumour, aniridia, genitourinary abnormalities, mental retardation) links WT to chromosome 11p13.

Purpose of the Study:

  • To investigate the precise location of the WT gene using high-resolution mapping.
  • To determine if defects in the WT gene contribute to gonadal abnormalities in WAGR syndrome.
  • To explore the role of the WT gene in genitourinary development.

Main Methods:

  • High-resolution physical mapping studies to pinpoint the WT gene.
  • Expression analysis of a candidate WT gene in developing kidney and gonadal tissues.

Related Experiment Videos

  • Correlation of gene mapping data with clinical features of WAGR syndrome.

    • Main Results:

    • High-resolution mapping studies refined the location of the WT gene.
    • Evidence suggests that gonadal abnormalities in WAGR patients may stem from WT gene defects.
    • A candidate WT gene was found to be expressed in critical regions of the developing kidney and embryonic gonads.

    Conclusions:

    • The WT gene is a key player in kidney development and is implicated in WAGR syndrome.
    • WT gene dysfunction likely contributes to gonadal abnormalities observed in WAGR patients.
    • The expression pattern supports a role for the WT gene in both renal and gonadal development.